This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A new study suggests physician practices acquired by private equity rely more heavily on advanced practice providers like nurse practitioners and physician assistants and experience higher churn compared with their non-private equity owned peers.
Castle Biosciences Presents Data at the DermatologyNurses’ Association 2021 Annual Convention Castle Biosciences Presents Data at the DermatologyNurses’ Association 2021 Annual Convention FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #DNANurses–Castle Biosciences, Inc.
Peter Marinkovich, primary investigator of the GEM-3 trial, director of the Blistering Disease Clinic at Stanford Health Care and associate professor of dermatology at the Stanford University School of Medicine.
And 37% of parents said they thought eczema affected their child’s performance when they were at school. My ‘butterfly skin’ could kill me. ” But she’s in a happier place. “I can now look in the mirror without thinking: ‘I don’t want to see you.'”
National Institute of Allergy and Infectious Diseases (NIAID), of bamlanivimab (LY-CoV555) decreased the risk of COVID-19 among residents and staff of long-term care facilities, i.e., nursing homes. It evaluated 965 participants who tested negative for COVID-19 at baseline, 299 residents and 666 staff.
Google has developed an AI-powered dermatology assist tool designed to detect conditions of the skin, hair and nails based on phone images taken by the user. The tool allows users to identify dermatologic issues such as a rash on the arm or nail discoloration using a phone camera. Development of the AI Dermatology Health Tool.
Immune-Mediated Skin and Dermatologic Adverse Reactions. Withhold YERVOY until specialist assessment for Grade 2 and permanently discontinue for Grade 3 or 4 exfoliative or bullous dermatologic conditions. Administer corticosteroids for Grade 3 or 4 rash. Immune-Mediated Encephalitis. Serious Adverse Reactions.
Immune-Mediated Skin and Dermatologic Adverse Reactions. Withhold YERVOY until specialist assessment for Grade 2 and permanently discontinue for Grade 3 or 4 exfoliative or bullous dermatologic conditions. Administer corticosteroids for Grade 3 or 4 rash. Immune-Mediated Encephalitis. Serious Adverse Reactions.
So go look they got some beautiful ads, UnitedHealthcare they send an email to their patients say once a week with some information educational information and big button saying click here if you want to see one of our doctors on demand here our partners and we’re gonna pay for that for you.
So go look they got some beautiful ads, UnitedHealthcare they send an email to their patients say once a week with some information educational information and big button saying click here if you want to see one of our doctors on demand here our partners and we’re gonna pay for that for you.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content